Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Aging 14, 68296839
For maintenance doses (7.5 to 15 mg), 20 mg/mL or higher reduces injection volume
Amrn D et al
Expression cloning of the pancreatic beta cell receptor for the gluco- incretin hormone glucagon-like peptide 1
VK0214, oral TR agonist for X-linked adrenoleukodystrophy (X-ALD) Recent Highlights: In June 2026, Viking announced that its working toward maintenance-dosing data for subcutaneous VK2735 and preparing to start Phase 3 trials of the oral tablet in Q4 2026, with the goal of becoming the first company to offer a dual GLP-1/GIP agonist in both oral and injectable form
Vrang and Grove, 2011
US$ 27.45
US$ 22.63
US$ 23.10
US$ 22.55
US$ 26.30
